The short version
12 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Vigabatrin
Vigabatrin · VIGABATRIN 500 mg/1 · Powder, For Solution · Oral · Aurobindo Pharma Limited
NDC 59651-0366-50 · 50 PACKET in 1 CARTON / 1 POWDER, FOR SOLUTION in 1 PACKET · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$300.00
Reported to Texas DSHS · 2026 annual filing · Aurobindo Pharma Usa, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2025)
$278,751
245 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $12,378.29 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Vigabatrin Shared System REMS
Regulatory
- Application
- ANDA213899
- TE code
- AA
- Approval date
- Sep 29, 2021
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Vigabatrin (Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Actavis Pharma, Inc. | VIGABATRIN 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | VIGABATRIN 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | VIGABATRIN 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | VIGABATRIN 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA, Inc. | VIGABATRIN 500 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddys Laboratories Inc., | VIGABATRIN 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Lundbeck Pharmaceuticals LLC | VIGABATRIN 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Par Health USA, LLC | VIGABATRIN 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Pharmaceuticals Inc. | VIGABATRIN 500 mg/.0005kg | Jul 15, 2026 | Sep 2, 2026 |
| Upsher-Smith Laboratories, LLC | VIGABATRIN 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | VIGABATRIN 500 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | VIGABATRIN 500 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Vigabatrin — NDC 59651-0366-50," retrieved September 3, 2026, https://drugdashboards.com/drug/59651036650.
Free to cite with attribution — see how the data is put together.